Aspire-Lakewood Holdings, Inc. SEC filings ASBP
Aspire-Lakewood Holdings, Inc. has 228 filings in SEC EDGAR's recent list, going back to Mar 16, 2021. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K/A |
Amended current report
Material agreement
|
Oct 20, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Auditor change
|
Sep 29, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Sep 9, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 19, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Aug 10, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Other events
|
Jul 20, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Other events
|
Jun 12, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 12, 2026 | Jun 12, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 14, 2026 | May 11, 2026 |
| DEFR14A | Filing | May 12, 2026 | — |
| DEF 14A | Proxy statement | May 8, 2026 | May 8, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 27, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2026 | Apr 20, 2026 |
| 8-K/A |
Amended current report
Material agreement, Bylaw or fiscal year change
|
Apr 17, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 16, 2026 | Apr 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 16, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 15, 2026 | Apr 15, 2026 |
| EFFECT | Filing | Apr 14, 2026 | — |
| CORRESP | Letter to the SEC | Apr 13, 2026 | — |
| S-1/A | Amended registration statement | Apr 10, 2026 | — |
| 10-K/A | Amended annual report | Apr 8, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| UPLOAD | Letter from the SEC | Feb 24, 2026 | — |
| DEF 14A | Proxy statement | Feb 24, 2026 | Feb 24, 2026 |
| S-1 | Registration statement | Feb 17, 2026 | — |
| PRE 14A | Preliminary proxy statement | Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Feb 12, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 6, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 30, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 15, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 13, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 6, 2026 | Jan 1, 2026 |
| EFFECT | Filing | Dec 12, 2025 | — |
| CORRESP | Letter to the SEC | Dec 11, 2025 | — |
| S-1 | Registration statement | Dec 3, 2025 | — |
| 10-Q/A | Amended quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Nov 14, 2025 | Nov 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 5, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 17, 2025 | Oct 15, 2025 |
| EFFECT | Filing | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| S-1/A | Amended registration statement | Sep 26, 2025 | — |
| 8-K |
Current report
Unregistered share sale, Auditor change
|
Sep 26, 2025 | Sep 22, 2025 |
| UPLOAD | Letter from the SEC | Sep 24, 2025 | — |
| DEF 14A | Proxy statement | Sep 23, 2025 | Sep 22, 2025 |
| S-1 | Registration statement | Sep 18, 2025 | — |
| PRE 14A | Preliminary proxy statement | Sep 8, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 22, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q/A | Amended quarterly report | Aug 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Other events
|
Jun 18, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 10, 2025 | Jun 10, 2025 |
| EFFECT | Filing | May 29, 2025 | — |
| CORRESP | Letter to the SEC | May 28, 2025 | — |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| S-1 | Registration statement | May 13, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 30, 2025 | Apr 24, 2025 |
| EFFECT | Filing | Apr 21, 2025 | — |
| CORRESP | Letter to the SEC | Apr 18, 2025 | — |
| 8-K |
Current report
Listing notice
|
Apr 18, 2025 | Apr 18, 2025 |
| UPLOAD | Letter from the SEC | Apr 16, 2025 | — |
| S-1 | Registration statement | Apr 9, 2025 | — |
| 10-K | Annual report | Apr 7, 2025 | Dec 31, 2024 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 21, 2025 | Feb 17, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Feb 20, 2025 | Feb 13, 2025 |
| 25-NSE | Delisting notice | Feb 19, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Feb 10, 2025 | Feb 4, 2025 |
| EFFECT | Filing | Jan 14, 2025 | — |
| 424B3 | Prospectus | Jan 14, 2025 | — |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| S-4/A | Filing | Jan 8, 2025 | — |
| 425 | Filing | Dec 26, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 26, 2024 | Dec 18, 2024 |
| S-4/A | Filing | Dec 23, 2024 | — |
| CORRESP | Letter to the SEC | Dec 23, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2024 | — |
| S-4/A | Filing | Dec 10, 2024 | — |
| CORRESP | Letter to the SEC | Dec 10, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2024 | — |
| S-4/A | Filing | Nov 15, 2024 | — |
| CORRESP | Letter to the SEC | Nov 15, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| UPLOAD | Letter from the SEC | Nov 8, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| 10-Q/A | Amended quarterly report | Oct 24, 2024 | Jun 30, 2024 |
| 10-Q/A | Amended quarterly report | Oct 24, 2024 | Mar 31, 2024 |
| CORRESP | Letter to the SEC | Oct 24, 2024 | — |
| S-4/A | Filing | Oct 24, 2024 | — |
| CORRESP | Letter to the SEC | Oct 23, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2024 | — |
| 425 | Filing | Oct 10, 2024 | — |
| 8-K |
Current report
Material agreement
|
Oct 10, 2024 | Oct 9, 2024 |
| UPLOAD | Letter from the SEC | Oct 8, 2024 | — |
| 425 | Filing | Oct 4, 2024 | — |
| 8-K |
Current report
Material agreement
|
Oct 4, 2024 | Oct 2, 2024 |
| S-4 | Registration for a merger or exchange | Sep 6, 2024 | — |
| 425 | Filing | Sep 6, 2024 | — |
| 8-K |
Current report
Material agreement
|
Sep 6, 2024 | Sep 5, 2024 |
| 8-K |
Current report
Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| 425 | Filing | Aug 30, 2024 | — |
| 8-K |
Current report
Material agreement
|
Aug 30, 2024 | Aug 26, 2024 |
| 10-Q | Quarterly report | Aug 16, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| RW | Filing | Aug 2, 2024 | — |
| 8-K |
Current report
Agreement ended
|
Jul 23, 2024 | Jul 19, 2024 |
| S-4/A | Filing | Jun 24, 2024 | — |
| 425 | Filing | Jun 7, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jun 7, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | Jun 5, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 28, 2024 | May 22, 2024 |
| 8-K |
Current report
Material agreement
|
May 22, 2024 | May 22, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 20, 2024 | May 20, 2024 |
| 8-K |
Current report
Other events
|
May 16, 2024 | May 16, 2024 |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| S-4/A | Filing | May 14, 2024 | — |
| DEF 14A | Proxy statement | May 1, 2024 | May 1, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2024 | Apr 18, 2024 |
| 10-K | Annual report | Mar 11, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Jan 31, 2024 | — |
| 425 | Filing | Jan 30, 2024 | — |
| S-4 | Registration for a merger or exchange | Jan 26, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| 425 | Filing | Dec 28, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Dec 28, 2023 | Dec 21, 2023 |
| UPLOAD | Letter from the SEC | Dec 26, 2023 | — |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Aug 23, 2023 | Aug 18, 2023 |
| 8-K |
Current report
Other events
|
Aug 14, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement
|
Jul 19, 2023 | Jul 14, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
May 24, 2023 | May 18, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
|
May 23, 2023 | May 18, 2023 |
| 8-K |
Current report
Material agreement
|
May 15, 2023 | May 9, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement
|
May 9, 2023 | May 3, 2023 |
| 8-K |
Current report
Other events
|
May 4, 2023 | May 3, 2023 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| 8-K |
Current report
Material agreement
|
May 1, 2023 | Apr 27, 2023 |
| DEF 14A | Proxy statement | Apr 21, 2023 | May 18, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2023 | Apr 5, 2023 |
| 10-K | Annual report | Mar 21, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change
|
May 19, 2022 | May 16, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Other events
|
Apr 8, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Other events
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 23, 2022 | Feb 17, 2022 |
| 424B4 | Prospectus | Feb 22, 2022 | — |
| EFFECT | Filing | Feb 17, 2022 | — |
| CERT | Filing | Feb 17, 2022 | — |
| 8-A12B | Form 8-a12b | Feb 17, 2022 | — |
| CORRESP | Letter to the SEC | Feb 15, 2022 | — |
| CORRESP | Letter to the SEC | Feb 15, 2022 | — |
| S-1/A | Amended registration statement | Feb 14, 2022 | — |
| CORRESP | Letter to the SEC | Jan 6, 2022 | — |
| S-1 | Registration statement | Dec 30, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2021 | — |
| DRS/A | Filing | Sep 7, 2021 | — |
| DRS/A | Filing | May 20, 2021 | — |
| DRSLTR | Filing | May 19, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2021 | — |
| DRS | Filing | Mar 16, 2021 | — |
Showing 173 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ASBP (Nasdaq), ASBPW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Estero, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1847345
- Former names
- Aspire Biopharma Holdings, Inc. (until Sep 9, 2026); PowerUp Acquisition Corp. (until Feb 19, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.